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A B S T R A C T
We present two cases in which takotsubo cardiomyopathy (TC) developed immediately after a diagnosis
of microvascular angina had been established. One patient who had been diagnosed as having
endothelium-dependent microvascular angina (microvascular spasm) developed TC three weeks after
the initial admission. The other patient was diagnosed as having endothelium-independent
microvascular angina (decreased coronary ﬂow reserve) and subsequently developed TC after the
discontinuation of nicorandil treatment. These cases may provide insight into the possible mechanisms
underlying the pathophysiological ﬁndings of TC.
<Learning objective: Impaired coronary microcirculation has been recently reported in many cases
during the acute phase of takotsubo cardiomyopathy. However, the exact mechanism responsible for the
coronary microvascular dysfunction associated with this entity remains unclear. This report highlights
the importance of microvascular angina, which may play a role in the development of this
cardiomyopathy.>
 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Takotsubo cardiomyopathy (TC) was ﬁrst described in 1991;
since then, several possible mechanisms, such as multivessel
epicardial spasm, catecholamine toxicity, plaque rupture, mid-
septal hypertrophy, and microvascular dysfunction, have been
proposed to explain its occurrence [1]. Despite being widely
recognized for more than two decades, its precise pathophysiology
remains unclear. We present two cases of TC occurring in patients
with microvascular angina, which suggest the possible underlying
mechanisms of this cardiomyopathy.
Case 1
A 76-year-old woman with a history of diabetes mellitus
presented to the emergency room with chest pain and palpitation.
Although her symptoms disappeared shortly after arrival, she was
admitted to the hospital because of suspected angina pectoris. She* Corresponding author at: Nihon University Hospital, 1-6, Kanda-Surugadai,
Chiyoda-ku, Tokyo 101-0062, Japan. Tel.: +81 03 3293 1711; fax: +81 03 3292 2880.
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1878-5409/ 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All righthad been taking glimepiride (1 mg/day) and diazepam (2 mg, as
needed). Routine laboratory studies on admission produced
normal results, with the exception of a higher hemoglobin A1c
level of 6.6%. An electrocardiogram (ECG) revealed normal ﬁndings,
and an echocardiography showed normal left ventricular ejection
fraction (LVEF, 69%). She underwent coronary angiography, which
revealed no signs of signiﬁcant atherosclerosis; an acetylcholine
(ACH) provocation test was subsequently performed to assess
coronary vasoconstriction. During the administration of ACH at a
dose of 50 mg into the left coronary artery, the patient reported
chest pain, and an ECG showed ST-segment elevation in the
inferior leads, which gradually extended to the precordial leads
(Fig. 1A). A coronary angiography revealed no evidence of
epicardial spasm, but ‘‘to-and-fro’’ phenomenon was observed
distal to the left anterior descending coronary artery (LAD), which
resolved after the intracoronary injection of nitroglycerin. These
ﬁndings were consistent with microvascular spasm, as previously
described by Mohri et al. [2]; consequently, diltiazem (200 mg/
day) was started to relieve the microvascular constriction. The
patient recovered with a partial improvement of her angina during
a 5-day hospital stay.
Three weeks later, she suffered from worsening chest pain
without any accompanying emotional or physical stress ands reserved.
Fig. 1.
(A) During the administration of acetylcholine into the left coronary artery, an electrocardiogram (ECG) showed ST-segment elevation in the inferior leads (large
arrows), which gradually extended to the precordial leads (small arrows). (B) An ECG performed at the second admission showed T wave inversions with
prolonged QT intervals in leads I, II, III, aVF, and V2 to V6. (C) The coronary ﬂow reserve (CFR) and the index of microcirculatory resistance (IMR) were 3.9 and 11,
respectively, at the time of the initial admission. (D) During apical ballooning, the CFR and IMR values were poorer than those observed during the previous
catheterization (i.e. the CFR and IMR values were 2.1 and 16, respectively). (E and F) An echocardiography showed apical hypokinesis with preserved basal
function (E, end-diastole; F, end-systole).
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mildly increased troponin-I level (0.82 ng/mL), and an ECG showed
T wave inversions with prolonged QT intervals in leads I, II, III, aVF,
and V2 to V6 (Fig. 1B). A coronary angiography revealed normal
ﬁndings, but the coronary ﬂow reserve (CFR) and the index of
microcirculatory resistance (IMR) in the LAD, which represent the
coronary microcirculatory state, were poorer than at the time of
the previous catheterization (i.e. CFR decreased from 3.9 to 2.1, and
IMR increased from 11 to 16) (Fig. 1C and D). An echocardiography
showed apical hypokinesis with preserved basal function, consis-
tent with TC (Fig. 1E and F). Nicorandil (15 mg/day) was
administered to further suppress the microvascular constriction.
The abnormal wall motion and ECG results resolved completely
within three days and six months, respectively.
Case 2
An 83-year-old woman with a history of well-controlled
hypertension and depression was referred to our hospital because
of chest pressure occurring during times of exercise and at rest. Shewas admitted to the hospital because a 99mTc-tetrofosmin
myocardial single photon emission computed tomography dem-
onstrated transient ischemic dilatation and reduced uptake in the
LAD territory. She had been taking metoprolol (60 mg/day) for
hypertension and ethyl loﬂazepate (1 mg/day) for depression. On
admission, an ECG showed sinus rhythm with left bundle branch
block. The laboratory data were normal, and an echocardiography
demonstrated normal left ventricular function (LVEF, 67%). She
underwent coronary angiography, which showed no apparent
epicardial obstruction. An ACH provocation test was not performed
because the patient’s lower back pain made her unsuitable for the
insertion of a temporary pacemaker. To assess the underlying
etiology, the coronary microcirculation was evaluated using a
pressure/temperature-sensing coronary wire. The CFR and IMR
were measured in the LAD, where the values were 1.6 and 23,
respectively (Fig. 2A). Although the association between IMR and
microvascular angina has not been well established, the decreased
CFR suggested microvascular dysfunction. Nicorandil treatment
(15 mg/day) was initiated but was discontinued four months later
because the patient suffered from severe headaches.
Fig. 2.
(A) The coronary ﬂow reserve (CFR) and index of microcirculatory resistance (IMR) values measured in the left anterior descending coronary artery were 1.6 and
23, respectively. (B) An electrocardiogram performed at the time of the second admission showed T wave inversions with prolonged QT intervals in leads II, III,
aVF, and V3 to V6. (C and D) An echocardiography revealed apical ballooning (C, end-diastole; D, end-systole).
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to our hospital because of the recurrence of chest pressure
occurring while she was doing housework. Her ECG showed T wave
inversions with prolonged QT intervals in leads II, III, aVF, and V3 to
V6 (Fig. 2B). An echocardiography revealed apical ballooning,
supporting a diagnosis of TC (Fig. 2C and D). Given these ﬁndings,
diltiazem (200 mg/day) was started instead of nicorandil, and
metoprolol was discontinued. The wall motion abnormality
recovered fully within a week.Discussion
To the best of our knowledge, this is the ﬁrst report of TC
spontaneously occurring in patients with microvascular angina.
Many researchers have reported the impairment of coronary
microcirculation during the acute phase of TC [3–6]. Even though
microcirculatory dysfunction has been observed in some clinical
settings, such as hyperlipidemia, diabetes mellitus, cigarette
smoking [7], and idiopathic dilated cardiomyopathy [8], the
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which is neither inﬂuences of concomitant coronary risk factors
nor a secondary phenomenon of contractile dysfunction, may play
a primary role in the pathophysiology of TC.
Kume et al. measured the coronary ﬂow velocity reserve (CFVR)
using a Doppler guidewire as an index of microvascular dysfunc-
tion within 24 h of symptom onset and three weeks later [3]. They
reported that a decreased CFVR, which had been observed during
the acute phase, improved normally during the follow-up period.
Galiuto et al. performed myocardial contrast echocardiography
within ﬁve days of symptom onset and found that the reduction in
myocardial perfusion observed in the region with myocardial
dysfunction had improved signiﬁcantly after one month
[4]. Daniels et al. ﬁrst described high microvascular resistance in
TC using a novel IMR [5], and Layland et al. also reported that high
IMR level observed soon after disease onset decreased to normal in
six weeks [6]. Although there is some dissent regarding
microvascular dysfunction in TC, the above ﬁndings suggest that
microvascular dysfunction and myocardial damage are only
observable during the ﬁrst few days of TC and then disappear
within a relatively short time.
Epicardial vasomotor abnormality is less frequent in TC. In a
previous systematic review, only 24 of 84 (28.6%) patients
experienced multivessel epicardial spasm after the injection of
ergonovine or ACH [9]. Recently, Patel et al. reported that the
magnitude of vasomotor dysfunction was greater in the microcir-
culation than in the epicardial arteries for this entity [10]. Impor-
tantly, they stated that 90% of patients had abnormal
microvascular vasomotion in response to either ACH or adenosine.
This ﬁnding was quite consistent with our cases: one had
endothelium-dependent microvascular dysfunction (microvascu-
lar spasm), and the other had endothelium-independent micro-
vascular dysfunction (decreased coronary ﬂow reserve).
Microcirculatory vasoconstriction is predominantly mediated by
a2-adrenoceptors; thus, a-adrenergic microvascular spasm,
which occurs after catecholamine excess, appears to be the most
plausible mechanism of TC. It remains to be established whether
endothelium-dependent and -independent microvascular dys-
functions can co-exist in a patient with microvascular angina.
Additionally, in our cases, it seems to be important to
understand why diltiazem and the discontinuation of nicorandil
failed to prevent the occurrence of TC. In case 1, the clinical course
including the ECG and echocardiography changes was consistent
with TC, but ﬁndings of these examinations were not as marked as
those of case 2. Diltiazem is widely used for the treatment of
vasospastic angina as a calcium channel blocker; so, even though
the patient had developed TC while taking diltiazem, the coronary
microvascular contractility might have improved, to some extent.
Nicorandil activates adenosine triphosphate-sensitive potassium
channels and increases coronary blood ﬂow. In a previous
experimental study, the intracoronary infusion of nicorandil
signiﬁcantly dilated smaller vessels less than 100 mm in diameter
[11]. Consequently, the abrupt withdrawal of nicorandil in case
2 might have destabilized the coronary microcirculation. These
ﬁndings also suggest the pathophysiological relevance of TC and
coronary microcirculatory instability.Both TC and microvascular angina commonly occur in elderly
women. Even though some variant forms of left ventricular
dysfunction have been reported, the unique abnormal apical and
midventricular wall motion of TC could be explained by a
difference in microvascular distribution. Further research is
needed to validate the potential role of microvascular angina in
TC, and further consideration should be given to assessments of
coronary microcirculation, especially in postmenopausal women.
Conclusion
These cases suggest that microvascular dysfunction is one of the
plausible mechanisms underlying the pathophysiological ﬁndings
of TC.
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